Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

被引：0
作者：
Antoine Leuzy
Claudia Cicognola
Konstantinos Chiotis
Laure Saint-Aubert
Laetitia Lemoine
Niels Andreasen
Henrik Zetterberg
Keqiang Ye
Kaj Blennow
Kina Höglund
Agneta Nordberg
机构：
[1] Karolinska Institutet,Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics
[2] University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy
[3] University of Toulouse,ToNIC, Toulouse NeuroImaging Center
[4] Inserm,Nuclear Medicine Department
[5] UPS,Theme Aging
[6] University Hospital of Toulouse,Clinical Neurochemistry Laboratory
[7] Karolinska University Hospital,Department of Neurodegenerative Disease
[8] Sahlgrenska University Hospital,Pathology & Laboratory Medicine, Experimental Pathology
[9] UCL Institute of Neurology,undefined
[10] UK Dementia Research Institute at UCL,undefined
[11] Emory University School of Medicine,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
Alzheimer’s disease; Tau; CSF; PET imaging; [; F]FDG; [; F]THK5317;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1152 / 1163
页数：11
相关论文
共 289 条
[1]  
Blennow K(2010)Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 131-144
[2]  
Hampel H(2013)Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807 J Alzheimers Dis 34 457-468
[3]  
Weiner M(2013)[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease Alzheimers Dement 9 666-676
[4]  
Zetterberg H(2016)Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly Neurology 87 920-926
[5]  
Chien DT(2016)The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging Brain 139 2249-2260
[6]  
Bahri S(2017)18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease EMBO Mol Med 9 1212-1223
[7]  
Szardenings AK(2018)Associations between [(18)F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample Neurology 90 e282-e290
[8]  
Walsh JC(1995)Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26 231-245
[9]  
Mu F(2005)Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology Clin Chem 51 336-345
[10]  
Su MY(2013)Characterization of novel CSF tau and ptau biomarkers for Alzheimer's disease PLoS One 8 38-581
12345678910